Randall Michael Giuffre

Insider Reports History

Entity
Individual
Location
2 Carlson Parkway, Suite 260, Minneapolis, MN
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Randall Michael Giuffre:

Insider Reports Filed by Randall Michael Giuffre

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jan 2, 2025 1 $58K 4 Jan 3, 2025 Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2024 1 $0 4 Jun 3, 2024 Director
DMAC DiaMedica Therapeutics Inc. Jan 2, 2024 1 $53.7K 4 Jan 2, 2024 Director
DMAC DiaMedica Therapeutics Inc. Jun 23, 2023 2 $254K 4 Jun 26, 2023 Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 Director
DMAC DiaMedica Therapeutics Inc. Jan 3, 2023 1 $53.7K 4 Jan 3, 2023 Director
DMAC DiaMedica Therapeutics Inc. Dec 8, 2022 2 $81K 4 Dec 12, 2022 Director
DMAC DiaMedica Therapeutics Inc. Dec 6, 2022 2 $34.7K 4 Dec 8, 2022 Director
DMAC DiaMedica Therapeutics Inc. Dec 1, 2022 1 $975 4 Dec 5, 2022 Director
DMAC DiaMedica Therapeutics Inc. Nov 29, 2022 3 $80.5K 4 Dec 1, 2022 Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
DMAC DiaMedica Therapeutics Inc. Jan 3, 2022 1 $53.8K 4 Jan 3, 2022 Director
DMAC DiaMedica Therapeutics Inc. Jul 15, 2021 1 $0 4 Jul 16, 2021 Director